Mounjaro Cost Without Insurance — and How to Pay Far Less

What Mounjaro Costs at Cash Price

When people ask how much Mounjaro is, the sticker number is the place to start — even though it's rarely what you end up paying. Mounjaro is Eli Lilly's tirzepatide injection, FDA-approved for type 2 diabetes, and it hits both the GLP-1 and GIP receptors. That dual action is partly why it tends to outperform semaglutide on weight and blood sugar, and partly why Lilly can charge a premium for it.

The published cash price — the wholesale acquisition cost (WAC) — lands at roughly $1,023 per month, and it doesn't budge by dose:

• Mounjaro 2.5mg (starting dose): $1,023/month
• Mounjaro 5mg: $1,023/month
• Mounjaro 7.5mg: $1,023/month
• Mounjaro 10mg: $1,023/month
• Mounjaro 12.5mg: $1,023/month
• Mounjaro 15mg (max dose): $1,023/month

That flat-dose pricing mirrors how Novo Nordisk prices Wegovy — you don't pay more as you titrate up. The detail that matters for your wallet: Mounjaro's cash price undercuts Wegovy's $1,349 by about $326 a month, and Lilly has been the more aggressive of the two manufacturers when it comes to coupons and self-pay deals. Those discounts are where the real savings live, so let's walk through them.

The Mounjaro Coupon: Down to $25

The single biggest price drop most people qualify for comes from the manufacturer coupon, and Lilly's is among the most generous in the entire GLP-1 category. The Mounjaro Savings Card is built for people who carry commercial (private) insurance:

• Copay reduction: Pay as little as $25 per month for Mounjaro
• Maximum savings: Up to $573 off per 28-day supply
• Duration: Valid for up to 24 months from activation
• Eligibility: Must have commercial (private) insurance; cannot be used with Medicare, Medicaid, or other government insurance

Here's the mechanic that trips people up: the card pays the difference between your insurer's share and a $25 copay — it isn't a flat $25 price tag. Because the discount is capped per fill, it can only knock so much off if your plan contributes nothing.

What that means for your bill:if your plan covers Mounjaro and your copay sits under $573, the card usually drops you to $25/month. If your plan won't cover it at all, the card trims the price to roughly $450–$550/month rather than the full $1,023 — helpful, but at that point a cheaper route below almost always wins.

Why Zepbound Can Be Cheaper

This is the trick most cost guides bury: Zepbound is the exact same molecule as Mounjaro(tirzepatide), just sold under a weight-management label instead of a diabetes one. Same drug, different box — and crucially, different prices and different ways to pay:

• Zepbound list price: ~$1,060/month
• LillyDirect self-pay price: $349/month for single-dose vials
• Zepbound Savings Card: As low as $25/month with commercial insurance

The headline here is LillyDirect's $349/month self-pay price. It's open to anyone who doesn't have Zepbound coverage, ships straight to your door, and asks for no insurance and no proof of income. For a cash buyer, that's a third of Mounjaro's sticker price for the identical medication.

So the math is simple. If you're paying out of pocket and the goal is weight loss, Zepbound through LillyDirect almost always beats buying Mounjaro at cash price. If you have a diabetes diagnosis and a plan that covers Mounjaro, the $25 coupon can edge it out — run both numbers before you fill.

What You Pay With Insurance

If you're insured, your real Mounjaro cost depends almost entirely on your formulary. The upside: plans cover it more readily than Wegovy, because Mounjaro's on-label use is diabetes — something insurers fund far more willingly than obesity. The catch: what you actually owe swings wildly from one plan to the next:

• With commercial insurance + savings card: As low as $25/month
• With insurance, no savings card: $50–$300/month typical copay
• Prior authorization: Almost always required; typically need documented A1C levels and failed metformin therapy
• Step therapy: Many plans require trying metformin, sulfonylurea, or SGLT2 inhibitor first
• Off-label for weight loss: Most commercial plans will not cover Mounjaro prescribed off-label for obesity without a diabetes diagnosis

Got a denial? Don't give up on coverage yet. Ask your prescriber to check whether Zepbound is covered under your plan's obesity benefit, because plenty of plans pay for Zepbound for weight loss while rejecting off-label Mounjaro — despite both being the identical tirzepatide. Switching the prescription, not the molecule, can be the cheapest fix.

Compounded Tirzepatide Pricing

The cheapest tirzepatide on paper isn't a brand at all — it's the compounded version, and it's still easier to find than compounded semaglutide. As of April 2026 the FDA hasn't officially called the tirzepatide shortage over, so compounding pharmacies can legally keep producing copies under the 503A and 503B exemptions. That window is what keeps the price low.

• Typical price range: $200–$500/month
• Available from: Compounding pharmacies and some telehealth platforms
• FDA-approved: No — compounded versions are not FDA-approved
• Quality concerns: Variable potency, sterility, and purity; no brand-equivalent quality controls

The cheap price comes with a real catch: the moment the FDA declares the shortage resolved, legal compounding can stop almost overnight. Treat the savings as temporary, not permanent. If you go this route, keep a fallback ready — LillyDirect at $349/month is the obvious one — so you're not scrambling if access gets pulled mid-titration.

Read our compounded vs brand comparison for a detailed safety and efficacy analysis.

Is There a Cheaper Pill Option?

People often ask whether a tablet would be cheaper or easier than the shot. For tirzepatide, the answer is no — there's no oral tirzepatide on the marketas of April 2026. Lilly has one in trials, but don't expect it before 2028, so it does nothing for your bill today.

If you specifically want to skip needles, your realistic (and sometimes cheaper) pill alternatives are different drugs entirely:

• Oral Wegovy (semaglutide tablet): $149/month at lowest dose, FDA-approved
• Oral semaglutide (Rybelsus): FDA-approved for diabetes; lower dose than Oral Wegovy

Bottom line: if you want tirzepatide's dual GLP-1/GIP punch, the injection is the only way to buy it right now. And cost aside, plenty of people actually prefer one weekly jab to a daily pill that has to be taken on an empty stomach with strict timing — convenience is part of the value, not just the dollar figure.